ALEXXA SAFKO: Open Payments
NPI 1841959681 · WEXFORD, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,311 in 164 payments from 19 companies in 2025. Trend: 2023 $990 · 2024 $920 · 2025 $2,311
Food & beverage: $2,311
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 81 | $1,091 |
| Janssen Biotech, Inc. | 26 | $272 |
| UCB, Inc. | 16 | $180 |
| Novartis Pharmaceuticals Corporation | 6 | $126 |
| Lilly USA, LLC | 9 | $120 |
| Amgen Inc. | 5 | $97 |
| GENZYME CORPORATION | 2 | $73 |
| PFIZER INC. | 3 | $57 |
| Regeneron Healthcare Solutions, Inc. | 2 | $52 |
| LEO Pharma Inc. | 2 | $44 |
Products named: RINVOQ, SKYRIZI, TREMFYA, Bimzelx, COSENTYX, DUPIXENT, Otezla, TALTZ.
Industry payments across PA — which companies pay providers there.
